Scholar Rock Holding Corporation $SRRK Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in shares of Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) by 2.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,887,410 shares of the company's stock after buying an additional 39,961 shares during the quarter. Geode Capital Management LLC owned 1.99% of Scholar Rock worth $66,861,000 at the end of the most recent reporting period.

• 3 Beaten-Down Stocks With Rebound Potential This Earnings Season

Several other large investors have also made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Scholar Rock by 2.1% during the first quarter. Vanguard Group Inc. now owns 4,845,205 shares of the company's stock worth $155,773,000 after purchasing an additional 101,723 shares during the last quarter. Adage Capital Partners GP L.L.C. raised its stake in shares of Scholar Rock by 26.5% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 2,018,000 shares of the company's stock valued at $64,879,000 after buying an additional 423,131 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Scholar Rock by 6.9% in the 1st quarter. Wellington Management Group LLP now owns 1,844,997 shares of the company's stock valued at $59,317,000 after buying an additional 119,375 shares during the period. Vestal Point Capital LP purchased a new stake in shares of Scholar Rock in the first quarter worth about $41,795,000. Finally, RA Capital Management L.P. boosted its stake in shares of Scholar Rock by 6,351.3% in the first quarter. RA Capital Management L.P. now owns 1,136,453 shares of the company's stock worth $36,537,000 after buying an additional 1,118,837 shares during the last quarter. 91.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Srinivas Akkaraju purchased 113,025 shares of the stock in a transaction dated Monday, October 6th. The shares were purchased at an average cost of $38.65 per share, with a total value of $4,368,416.25. Following the completion of the purchase, the director directly owned 500,439 shares of the company's stock, valued at approximately $19,341,967.35. The trade was a 29.17% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Mo Qatanani sold 3,353 shares of the stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $30.67, for a total value of $102,836.51. Following the completion of the transaction, the insider directly owned 108,964 shares of the company's stock, valued at approximately $3,341,925.88. This represents a 2.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 7,537 shares of company stock worth $242,088. Insiders own 13.30% of the company's stock.

Scholar Rock Price Performance

Scholar Rock stock opened at $40.21 on Monday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 6.33 and a current ratio of 6.33. The company's fifty day moving average price is $33.17 and its 200 day moving average price is $33.66. The stock has a market capitalization of $4.10 billion, a P/E ratio of -13.82 and a beta of 0.79. Scholar Rock Holding Corporation has a 1 year low of $22.71 and a 1 year high of $46.98.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.88) by ($0.02). During the same quarter last year, the firm earned ($0.66) EPS. As a group, equities research analysts anticipate that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on SRRK. JPMorgan Chase & Co. boosted their price target on Scholar Rock from $46.00 to $47.00 and gave the company an "overweight" rating in a report on Tuesday, November 18th. Raymond James Financial set a $53.00 target price on shares of Scholar Rock and gave the company a "strong-buy" rating in a research note on Wednesday, July 30th. Bank of America began coverage on shares of Scholar Rock in a report on Thursday, October 9th. They set a "buy" rating and a $53.00 price target on the stock. Barclays lifted their price objective on shares of Scholar Rock from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Monday, November 17th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Scholar Rock in a research note on Wednesday, October 8th. Four equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $48.33.

View Our Latest Stock Report on Scholar Rock

Scholar Rock Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

Read More

• Five stocks we like better than Scholar Rock
• How is Compound Interest Calculated?
• DoorDash’s Recent Stock Dip Equals 60% Upside
• Why Invest in High-Yield Dividend Stocks?
• Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
• What Are Treasury Bonds?
• Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scholar Rock Right Now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here